Revalesio Corporation

1202 E D St Ste 101, Tacoma, Washington, United States

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

50.0%

Phase 1

42.9%

Not Applicable

7.1%

Trial Status Distribution

Active, not recruiting

7.1%

Completed

50.0%

Terminated

7.1%

Withdrawn

35.7%

Clinical Trials

Trials sponsored by this organization (14)

Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Phase 2

Withdrawn

interventional

Oct 2026140 participants

Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy

Phase 2

Completed

interventional

Jul 202183 participants

Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis

Not Applicable

Terminated

interventional

Aug 20159 participants

Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma

Phase 1

Completed

interventional

Jun 201265 participants

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Phase 1

Completed

interventional

Jul 201112 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

Revalesio Corporation

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (14)

Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy

Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis

Systemic Bioactivity of Inhaled Nebulized RNS60

Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge

To Assess the Effect of RNS60 and Budesonide in Asthmatic Patients

Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Approvals

News